Ratings
0
Nobody has rated this yet. Be the first!
Works
2
Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS).
Personalized surveillance for hepatocellular carcinoma in cirrhosis - using machine learning adapted to HCV status
